Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer
Go back to Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 82.85 +0.09 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.76 | 52 Week High | $8.22 | |||
| Open | $83.75 | 52 Week Low | $3.07 | |||
| Day High | $85.98 | P/E | N/A | |||
| Day Low | $82.36 | EPS | $-1.30 | |||
| Volume | 1,335,818 | |||||
